Profile
ABVX VRTX REGN SGEN ARGX ALNY
Company Name ABIVAX SA Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $428.08M $128.84B $64.28B $43.15B $39.39B $33.74B
Employees 0.07K 6.10K 15.16K 3.26K 1.60K 2.23K
CEO Mr. Marc M. P. de Garidel M.B.A. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc. Dr. Yvonne L. Greenstreet M.B.A., M.D.
Ratings
ABVX VRTX REGN SGEN ARGX ALNY
Quant Rating Score 1 2 4 3 3 1
Quant Rating Strong Sell Sell Buy Neutral Neutral Strong Sell
Trading
ABVX VRTX REGN SGEN ARGX ALNY
Last Close $6.71 $424.99 $527.78 $228.74 $549.65 $251.15
High 52 $14.43 $516.74 $1201.76 $228.74 $671.75 $296.75
Low 52 $5.24 $396.64 $527.78 $228.74 $356.01 $146.93
Price vs. 52 Week High -53.5 % -17.76 % -56.08 % 0 % -18.18 % -15.37 %
Price vs. 52 Week Low 28.05 % 7.15 % 0 % 0 % 54.39 % 70.93 %
Total Return
ABVX VRTX REGN SGEN ARGX ALNY
1 Month Return 19.4 % -10.62 % -3.41 % 0 % 0.63 % 10.99 %
3 Month Return 0 % -9.57 % -23.55 % 0 % -14.97 % -8.36 %
6 Month Return -35.91 % -17.76 % -36.29 % 0 % -7.78 % -9.47 %
9 Month Return -40.04 % -9.28 % -53.35 % 0 % 2.74 % -6.82 %
YTD Return -8.33 % 5.54 % -25.91 % 0 % -10.63 % 6.73 %
1 Year Return -52.38 % 0.52 % -45.8 % 0 % 46.72 % 66.91 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABVX VRTX REGN SGEN ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.15 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -242.99 % -1.65 % 3.85 % -2.27 % -44.32 % -1.49 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
ABVX VRTX REGN SGEN ARGX ALNY
Gross Profit Margin TTM 92.28 % 86.09 % 84.94 % 72.37 % 46.33 % 86.01 %
Return on Assets TTM -85.88 % -2.38 % 11.98 % -11.76 % 13.45 % -6.4 %
Return on Equity TTM -211 % -3.28 % 14.77 % -16.53 % 16.83 % -509.33 %
Return on Capital Employed TTM -160.59 % -1.3 % 11.35 % -16.87 % -0.31 % -3.68 %
Net Income Per EBT TTM 96.36 % -215.53 % 90.27 % 100.55 % 25990.14 % 75.89 %
EBT Per Ebit TTM 102.39 % -100.69 % 129.3 % 94.01 % -18.79 % 308.03 %
EBIT Per Revenue TTM -2632.15 % -2.24 % 27.37 % -36.09 % -0.77 % -4.91 %
Cash Flow To Debt Ratio TTM -161.67 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Receivables Turnover TTM 0.43 6.84 2.53 1.98 2.46 5.62
Payables Turnover TTM 0.02 3.71 3.01 1.54 1.83 3.37
Inventory Turnover TTM - 1.27 0.66 0.65 2.93 5.01
Fixed Asset Turnover TTM 254.54 % 425.82 % 300.07 % 256.83 % 5106.8 % 337.41 %
Asset Turnover TTM 3.31 % 48.84 % 37.52 % 34.46 % 35.83 % 55.72 %
Operating Cash Flow Per Share TTM -2.46 -1.91 37.05 -1.12 -1.07 -0.35
Free Cash Flow Per Share TTM -2.47 -3.07 28.3 -1.62 -1.09 -0.58
Cash Per Share TTM 228.35 % 2375.11 % 7825.12 % 657.5 % 4597.04 % 2024.29 %
Operating Cash Flow Sales Ratio TTM -2291.69 % -4.48 % 28.06 % -16.85 % -3.54 % -1.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.41 % 160.43 % 76.4 % 144.14 % 102.26 % 167.11 %
Cash Flow Coverage Ratios TTM -161.67 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Price To Free Cash Flows Ratio TTM -2.46 -163.02 21.29 -141.85 -505.86 -447.57
Price To Operating Cash Flows Ratio TTM -2.46 -261.97 16.35 -203.89 -601.06 -745.64
Price Cash Flow Ratio TTM -2.46 -261.97 16.35 -203.89 -601.06 -745.64
Income Statement (TTM)
ABVX VRTX REGN SGEN ARGX ALNY
Revenue $0.01B $11.02B $14.2B $1.96B $2.19B $2.25B
Gross Profit $0.01B $9.49B $12.23B $1.55B $1.96B $1.92B
Gross Profit Ratio 100% 86.11% 86.13% 79.1% 89.62% 85.62%
EBITDA $-0.17B $0.48B $5.32B $-0.62B $0B $-0.18B
Net Income $-0.18B $-0.54B $4.41B $-0.61B $0.83B $-0.28B
EPS Diluted -2.8 -2.08 38.34 -3.3 12.78 -2.16
Balance Sheet (MRQ)
ABVX VRTX REGN SGEN ARGX ALNY
Long Term Debt $0.05B $1.66B $1.98B $0.04B $0.03B $0B
Total Liabilities $0.16B $6.12B $8.41B $0.87B $0.7B $4.17B
Total Equity $0.04B $16.41B $29.35B $2.8B $5.5B $0.07B
Total Investments $0B $6.65B $15.42B $1.42B $1.93B $1.73B
Total Debt $0.1B $1.75B $2.7B $0.04B $0.04B $1.3B
Total Assets $0.21B $22.53B $37.76B $3.67B $6.2B $4.3B
Cash Flow Statement (TTM)
ABVX VRTX REGN SGEN ARGX ALNY
Net Income $-0.18B $-0.54B $4.41B $-0.61B $0.8B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.23B $-0.09B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.15B $-0.49B $4.42B $-0.45B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.31
ABCL AbCellera Biologics Inc. 2.03
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.27
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 0.9801
ABPWW 0.02
ABSI Absci Corporation 2.75
ABUS Arbutus Biopharma Corporation 3.23
ABVC ABVC BioPharma, Inc. 1.21
ACAD ACADIA Pharmaceuticals Inc. 17.44
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6099
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.35
ACIU AC Immune SA 1.68
ACLX Arcellx, Inc. 57.55
ACRV Acrivon Therapeutics, Inc. Common Stock 1.16
ETFs With Exposure to ABVX
Ticker ETF Name Weight Percentage Price
DBEZ Xtrackers MSCI Eurozone Hedged Equity ETF 0 51.58
BOUT Innovator IBD Breakout Opportunities ETF 2.56 33.755
SPEU SPDR Portfolio Europe ETF 0.001445 46.49
SXRJ.DE iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0665 302.15
CES1.L iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0539 25562.5
Unlock